The role of histone deacetylase 2 (HDAC2) and glucocorticoid receptor (GR) isoforms α, β in patients with asthma–COPD overlap syndrome (ACOS)

Elena Vsevolodskaia (Saint-Petersburg, Russian Federation), Elena Vsevolodskaia, Zhanna Mironova, Anna Ulitina, Vasily Trofimov, Sophia Pchelina, Michael Dubina

Source: International Congress 2016 – Molecular targets in pulmonary disease
Session: Molecular targets in pulmonary disease
Session type: Thematic Poster
Number: 879
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Elena Vsevolodskaia (Saint-Petersburg, Russian Federation), Elena Vsevolodskaia, Zhanna Mironova, Anna Ulitina, Vasily Trofimov, Sophia Pchelina, Michael Dubina. The role of histone deacetylase 2 (HDAC2) and glucocorticoid receptor (GR) isoforms α, β in patients with asthma–COPD overlap syndrome (ACOS). Eur Respir J 2016; 48: Suppl. 60, 879

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Involvement of coactivator associated arginine methyltransferase 1 (CARM1) in development of elastase-induced progressive emphysema
Source: Annual Congress 2013 –Novel mechanisms in lung injury
Year: 2013


Sputum cell mRNA transcripts demonstrate alteration of endothelin metabolism in severe asthma and COPD
Source: Annual Congress 2013 –New drugs in respiratory medicine
Year: 2013

microRNA-223 suppresses histone deacetylase 2 in chronic obstructive pulmonary disease
Source: International Congress 2015 – Latest news on miRNAs in pulmonary research
Year: 2015


The role of glucocorticoid receptor a and ß isoforms in exacerbations of asthma, COPD, and ACOS
Source: International Congress 2017 – Gene signatures in bronchial diseases
Year: 2017


Smoking cessation but not inhaled corticosteroids (ICS) can increase histone deacetylase 2 (HDAC2)] in COPD
Source: Annual Congress 2010 - Novel mechanisms in COPD
Year: 2010

Sputum levels of miR-145 and miR-338 in COPD, asthma and ACOS subjects
Source: International Congress 2016 – Mechanisms of disease
Year: 2016

Glucocorticosteroid receptor (GCR) gene isoforms expression in bronchial asthma (BA) patients
Source: Annual Congress 2011 - Asthma: a heterogeneous disease
Year: 2011


Expression of vascular remodeling markers in relation to bradykinin receptors in asthma and COPD
Source: Annual Congress 2013 –Emerging new targets for the treatment of respiratory diseases
Year: 2013


-82 A>G promoter polymorphism in the gene of human macrophage elastase (MMP-12) as a risk factor for COPD and bronchial asthma
Source: International Congress 2014 – Basic and translational research in asthma and COPD
Year: 2014


Egr-1 regulates muc5ac expression through activator protein-1 (AP-1) in chronic airway inflammation diseases
Source: International Congress 2015 – Translational studies in airway cell biology
Year: 2015


Mast cell gene signature enrichment associates with late-onset severe asthma
Source: International Congress 2016 – Phenotyping asthma
Year: 2016


Association of angiopoietin-like protein 4 with cardiovascular function in patients with COPD
Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities
Year: 2016

Characterizations and potential functions of protein arginine methyltransferase 1 in primary lung structural cells
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015

LATE-BREAKING ABSTRACT: miR-877 and its target protein HDAC6 are involved in airway inflammation
Source: International Congress 2015 – Emerging strategies for airway disease treatments
Year: 2015

Expression of mRNA chemokine and their receptors in nasopharingeal brush-biopsies represents age of bronchial asthma patients
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013

TNFAIP3 (A20) expression is elevated in the sputum of severe asthmatics
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016


Platelet activating factor receptor (PAFr) expression is increased in airways of COPD patients but is not attenuated by inhaled corticosteroid (ICS)
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013

Therapeutic blockade of IL-4 and 13 signaling with dupilumab (SAR231893/REGN668) inhibits key biomarkers in asthma
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013

Autoreactivity and inflammatory phenotypes in patients with COPD and bronchial asthma
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016

The role of suppressor of cytokine signalling 1 (SOCS1) in virus-induced asthma exacerbations
Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab
Year: 2016